Mortazawi Dermatologie
- Address
- Schwelmer Str. 25, 42897 Remscheid, Germany
Mortazawi Dermatologie - Specialized Dermatology Research
Mortazawi Dermatologie is a specialized dermatology research center focused on advancing treatment options for complex skin conditions. The center demonstrates expertise in conducting clinical trials for chronic inflammatory dermatological disorders, with particular emphasis on conditions requiring innovative therapeutic approaches.
- Hidradenitis Suppurativa treatment development and evaluation
- First-line therapy clinical trials for inflammatory skin conditions
- Novel therapeutic agents for chronic dermatological diseases
The center's research portfolio includes Phase 2 randomized, double-blind, placebo-controlled studies designed to evaluate the clinical efficacy of emerging treatments for patients with active mild to moderate Hidradenitis Suppurativa. Through rigorous scientific investigation, Mortazawi Dermatologie contributes to expanding treatment options for patients suffering from challenging dermatological conditions that significantly impact quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Mortazawi Dermatologie
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of JNJ-77242113 in Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study | Janssen Cilag International | Phase III | Not Recruiting | Dec 2023 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sar444656 | 2 | Unknown | 2023-12-27 | 2024-02-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.